FOR PROVIDERS
Our Device Suite
No bigger than a bandaid!
ZywieNano™ MCT Patch is a miniaturized biosensor
With advanced rhythm analysis and near real-time visibility, the ZywieNano™ is more than a wearable heart monitor. It's a clinical-grade medical device built for the way patients actually live. Your heart doesn't take a break, and neither do we. Zywie's connected cardiac monitoring transforms every beat into actionable insight, capturing the electrical activity of the human heart to enable proactive care that adapts as patients' needs evolve.
90mm
28mm
Designed with Patient and Provider In Mind
One device for all patients' needs
Patients can easily log symptoms and daily activities, pairing clinical events with ECG data to provide critical context for accurate interpretation. No chest strap, pulse oximeters, or separate fitness trackers required.
Faster results for healthcare providers
No more waiting for the device to be returned to the company or clinic to access results. Near real-time data transmission means your care team gets the information it needs faster, supporting better clinical outcomes.
Ability to monitor for 30 days
Live data transmission
Beat-to-beat analysis
Full disclosure on-demand
Notifications in near-real-time
At the Heart of Innovation
Technology that extends care beyond the clinic
Zywie® puts you in control with customizable notification parameters, ensuring you're alerted only to clinically significant heart rhythms that matter. Unlike a standard Holter monitor, which requires the device to be returned before results can be reviewed, ZywieNano™ delivers heart rate data in near real-time directly to your team. No more distractions from irrelevant calls or faxes. Just the information you need, when you need it.
Get in Touch
16–28%
Higher Detection
The results are clear: ordering ZywieNano™ for 30 days yields higher detection of first atrial fibrillation, pause, and ventricular tachycardia compared to a 14-day wearable device monitor, making it the gold standard choice for patients at higher risk of undetected cardiovascular disease.
Detected in 1-7 days
Detected in 8-14 days
Detected in 15-21 days
Detected in 22-30 days
FOR PROVIDERS
Frequently Asked Questions
What makes ZywieNano™ different from a standard Holter monitor?
Traditional Holter monitors require patients to return the device before providers can review results, creating delays in diagnosis. ZywieNano™ transmits heart rate and ECG data in near real-time, so your care team can act on clinically significant findings as they happen, without waiting for device retrieval.
How does ZywieNano™ compare to consumer wearables like Apple Watch or Fitbit devices?
Consumer wearables like Apple Watch, smart rings, and Fitbit devices are designed for general heart rate monitoring and fitness tracking. ZywieNano™ is a clinical-grade medical device purpose-built to detect abnormal heart rhythms, including atrial fibrillation and ventricular tachycardia, with the accuracy required for physician-reviewed diagnosis and treatment decisions.
How long can a patient wear the ZywieNano™ device?
ZywieNano™ is designed to monitor continuously for up to 30 days. Extended monitoring windows are critical for detecting arrhythmias that may not appear during a shorter observation period. Studies show 16–28% higher detection rates for AF, pause, and VT compared to 14-day monitoring.
Is ZywieNano™ comfortable for patients to wear in daily life?
Yes. At just 90mm x 28mm, no bigger than a bandaid, ZywieNano™ is designed to stay out of the way during daily life. Patients can wear it continuously without the bulk or discomfort associated with a traditional chest strap or multi-lead monitor.
Can patients log symptoms during monitoring?
Absolutely. Patients can log symptoms and activities directly through the smartphone app, pairing personal events with ECG data. This context helps providers make more accurate interpretations and identify correlations between symptoms like chest pain and underlying heart rhythm irregularities.
What arrhythmias can ZywieNano™ help detect?
ZywieNano™ is designed to detect a range of clinically significant arrhythmias, including atrial fibrillation, ventricular tachycardia, and pause events. Its 30-day monitoring window and beat-to-beat analysis make it well-suited for patients with intermittent symptoms or elevated risk factors for cardiovascular disease.
Join Us in Revolutionizing Cardiology – Let's Transform Heart Health Together
Get in Touch
